OrthoPediatrics (2X7) Ratios
0 Followers
OrthoPediatrics Ratios
DE:2X7's free cash flow for Q3 2026 was $1.59M. For the 2026 fiscal year, DE:2X7's free cash flow was decreased by $-2.91M and operating cash flow was $4.51M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 5.55 | 6.98 | 5.44 | 7.34 | 4.50 |
| Quick Ratio | 2.65 | 3.54 | 2.90 | 4.81 | 2.56 |
| Cash Ratio | 0.42 | 1.29 | 0.75 | 0.29 | 0.30 |
| Solvency Ratio | -0.11 | -0.16 | -0.06 | 0.29 | -0.07 |
| Operating Cash Flow Ratio | -0.11 | -0.80 | -0.65 | -0.71 | -0.44 |
| Short-Term Operating Cash Flow Coverage | -28.54 | -169.05 | -177.93 | -151.15 | -1.00 |
| Net Current Asset Value | $ 94.39M | $ 118.53M | $ 164.78M | $ 177.64M | $ 50.62M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.20 | 0.17 | 0.02 | 0.00 | 0.09 |
| Debt-to-Equity Ratio | 0.29 | 0.23 | 0.03 | 0.00 | 0.13 |
| Debt-to-Capital Ratio | 0.22 | 0.19 | 0.03 | 0.00 | 0.11 |
| Long-Term Debt-to-Capital Ratio | 0.22 | 0.17 | 0.03 | 0.00 | 0.06 |
| Financial Leverage Ratio | 1.47 | 1.33 | 1.16 | 1.13 | 1.37 |
| Debt Service Coverage Ratio | -2.03 | -5.80 | -52.91 | -1.46 | -0.40 |
| Interest Coverage Ratio | -4.84 | -11.26 | 0.00 | -10.48 | -8.02 |
| Debt to Market Cap | 0.24 | 0.14 | 0.01 | 0.00 | 0.02 |
| Interest Debt Per Share | 4.52 | 3.62 | 0.44 | 0.16 | 1.60 |
| Net Debt to EBITDA | -6.66 | -1.83 | 2.51 | 0.93 | -2.71 |
| Profitability Margins | |||||
| Gross Profit Margin | 73.05% | 72.58% | 74.80% | 74.14% | 74.86% |
| EBIT Margin | -14.04% | -19.20% | -17.32% | -17.82% | -18.23% |
| EBITDA Margin | -5.11% | -9.88% | -5.63% | -7.11% | -7.34% |
| Operating Profit Margin | -12.27% | -14.42% | -17.99% | -20.77% | -18.38% |
| Pretax Profit Margin | -16.58% | -20.48% | -14.33% | -3.02% | -17.73% |
| Net Profit Margin | -16.78% | -18.47% | -14.10% | 1.03% | -16.58% |
| Continuous Operations Profit Margin | -16.78% | -18.47% | -14.10% | 1.03% | -16.58% |
| Net Income Per EBT | 101.17% | 90.20% | 98.41% | -34.10% | 93.51% |
| EBT Per EBIT | 135.14% | 142.03% | 79.67% | 14.52% | 96.47% |
| Return on Assets (ROA) | -7.80% | -7.99% | -4.78% | 0.29% | -5.27% |
| Return on Equity (ROE) | -11.44% | -10.67% | -5.56% | 0.33% | -7.21% |
| Return on Capital Employed (ROCE) | -6.27% | -6.72% | -6.74% | -6.40% | -6.47% |
| Return on Invested Capital (ROIC) | -6.27% | -6.03% | -6.63% | 2.18% | -5.78% |
| Return on Tangible Assets | -12.33% | -12.68% | -7.75% | 0.48% | -9.78% |
| Earnings Yield | -9.52% | -7.07% | -2.85% | 0.15% | -1.41% |
| Efficiency Ratios | |||||
| Receivables Turnover | 4.39 | 4.83 | 4.30 | 4.93 | 5.46 |
| Payables Turnover | 3.39 | 6.30 | 2.96 | 2.84 | 2.64 |
| Inventory Turnover | 0.48 | 0.48 | 0.35 | 0.40 | 0.43 |
| Fixed Asset Turnover | 4.77 | 3.48 | 3.62 | 3.57 | 3.44 |
| Asset Turnover | 0.46 | 0.43 | 0.34 | 0.29 | 0.32 |
| Working Capital Turnover Ratio | 1.14 | 1.06 | 0.78 | 0.82 | 0.86 |
| Cash Conversion Cycle | 742.25 | 778.46 | 992.63 | 847.69 | 781.27 |
| Days of Sales Outstanding | 83.14 | 75.52 | 84.95 | 74.02 | 66.79 |
| Days of Inventory Outstanding | 766.77 | 760.87 | 1030.86 | 902.34 | 852.58 |
| Days of Payables Outstanding | 107.67 | 57.93 | 123.19 | 128.67 | 138.10 |
| Operating Cycle | 849.91 | 836.39 | 1115.81 | 976.36 | 919.37 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.21 | -1.17 | -1.19 | -1.05 | -0.68 |
| Free Cash Flow Per Share | -0.68 | -1.79 | -2.03 | -1.54 | -1.51 |
| Dividend Paid and CapEx Coverage Ratio | -0.44 | -1.90 | -1.42 | -2.17 | -0.82 |
| Capital Expenditure Coverage Ratio | -0.44 | -1.90 | -1.42 | -2.17 | -0.82 |
| Operating Cash Flow Coverage Ratio | -0.05 | -0.33 | -2.69 | -24.00 | -0.46 |
| Operating Cash Flow to Sales Ratio | -0.02 | -0.13 | -0.18 | -0.18 | -0.13 |
| Free Cash Flow Yield | -3.83% | -7.72% | -6.24% | -3.87% | -2.52% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -10.51 | -14.13 | -35.15 | 653.89 | -70.93 |
| Price-to-Sales (P/S) Ratio | 1.76 | 2.61 | 4.96 | 6.73 | 11.76 |
| Price-to-Book (P/B) Ratio | 1.20 | 1.51 | 1.96 | 2.17 | 5.12 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -26.10 | -12.95 | -16.02 | -25.87 | -39.67 |
| Price-to-Operating Cash Flow Ratio | -85.89 | -19.78 | -27.26 | -37.79 | -88.30 |
| Price-to-Earnings Growth (PEG) Ratio | -3.45 | -0.18 | 0.02 | -6.11 | 1.32 |
| Enterprise Value Multiple | -41.17 | -28.28 | -85.45 | -93.72 | -163.04 |
| Enterprise Value | 497.07M | 572.03M | 716.18M | 814.51M | 1.17B |
| EV to EBITDA | -41.17 | -28.28 | -85.45 | -93.72 | -163.04 |
| EV to Sales | 2.10 | 2.79 | 4.82 | 6.66 | 11.96 |
| EV to Free Cash Flow | -31.14 | -13.85 | -15.56 | -25.62 | -40.34 |
| EV to Operating Cash Flow | -102.47 | -21.15 | -26.48 | -37.42 | -89.79 |
| Tangible Book Value Per Share | 6.80 | 7.78 | 9.21 | 10.24 | 4.32 |
| Shareholders’ Equity Per Share | 14.77 | 15.36 | 16.63 | 18.29 | 11.70 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.01 | 0.10 | 0.02 | 1.34 | 0.06 |
| Revenue Per Share | 10.07 | 8.87 | 6.56 | 5.91 | 5.09 |
| Net Income Per Share | -1.69 | -1.64 | -0.92 | 0.06 | -0.84 |
| Tax Burden | 1.01 | 0.90 | 0.98 | -0.34 | 0.94 |
| Interest Burden | 1.18 | 1.07 | 0.83 | 0.17 | 0.97 |
| Research & Development to Revenue | 0.04 | 0.05 | 0.07 | 0.07 | 0.06 |
| SG&A to Revenue | 0.81 | 0.82 | 0.49 | 0.47 | 0.47 |
| Stock-Based Compensation to Revenue | 0.08 | 0.07 | 0.07 | 0.05 | 0.06 |
| Income Quality | 0.12 | 0.72 | 1.29 | -17.30 | 0.80 |
Currency in USD
